nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—urine—polycystic ovary syndrome	0.0936	0.179	CbGeAlD
Acetazolamide—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.0341	0.198	CcSEcCtD
Acetazolamide—AQP1—adrenal cortex—polycystic ovary syndrome	0.0248	0.0474	CbGeAlD
Acetazolamide—Appetite absent—Metformin—polycystic ovary syndrome	0.0229	0.133	CcSEcCtD
Acetazolamide—AQP1—endometrium—polycystic ovary syndrome	0.0221	0.0423	CbGeAlD
Acetazolamide—AQP1—uterus—polycystic ovary syndrome	0.0204	0.039	CbGeAlD
Acetazolamide—AQP1—pituitary gland—polycystic ovary syndrome	0.02	0.0383	CbGeAlD
Acetazolamide—AQP1—adipose tissue—polycystic ovary syndrome	0.02	0.0381	CbGeAlD
Acetazolamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0187	0.0357	CbGeAlD
Acetazolamide—AQP1—adrenal gland—polycystic ovary syndrome	0.0179	0.0342	CbGeAlD
Acetazolamide—AQP1—female gonad—polycystic ovary syndrome	0.0167	0.0319	CbGeAlD
Acetazolamide—AQP1—vagina—polycystic ovary syndrome	0.0166	0.0317	CbGeAlD
Acetazolamide—CYP3A4—urine—polycystic ovary syndrome	0.0161	0.0308	CbGeAlD
Acetazolamide—AQP1—endocrine gland—polycystic ovary syndrome	0.0155	0.0297	CbGeAlD
Acetazolamide—CA3—uterus—polycystic ovary syndrome	0.015	0.0286	CbGeAlD
Acetazolamide—CA3—pituitary gland—polycystic ovary syndrome	0.0147	0.0281	CbGeAlD
Acetazolamide—CA3—adipose tissue—polycystic ovary syndrome	0.0146	0.028	CbGeAlD
Acetazolamide—Blood disorder—Metformin—polycystic ovary syndrome	0.0136	0.079	CcSEcCtD
Acetazolamide—CA3—vagina—polycystic ovary syndrome	0.0122	0.0233	CbGeAlD
Acetazolamide—CA14—adrenal gland—polycystic ovary syndrome	0.0119	0.0228	CbGeAlD
Acetazolamide—CA3—endocrine gland—polycystic ovary syndrome	0.0114	0.0218	CbGeAlD
Acetazolamide—CA9—endocrine gland—polycystic ovary syndrome	0.0109	0.0208	CbGeAlD
Acetazolamide—CA5B—adipose tissue—polycystic ovary syndrome	0.0093	0.0178	CbGeAlD
Acetazolamide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00848	0.0491	CcSEcCtD
Acetazolamide—CA5B—adrenal gland—polycystic ovary syndrome	0.00834	0.0159	CbGeAlD
Acetazolamide—CA1—adipose tissue—polycystic ovary syndrome	0.00821	0.0157	CbGeAlD
Acetazolamide—CA2—embryo—polycystic ovary syndrome	0.00807	0.0154	CbGeAlD
Acetazolamide—CA12—endocrine gland—polycystic ovary syndrome	0.00806	0.0154	CbGeAlD
Acetazolamide—CA5B—vagina—polycystic ovary syndrome	0.00773	0.0148	CbGeAlD
Acetazolamide—CA5B—endocrine gland—polycystic ovary syndrome	0.00723	0.0138	CbGeAlD
Acetazolamide—CA2—adrenal cortex—polycystic ovary syndrome	0.00661	0.0126	CbGeAlD
Acetazolamide—CA4—pituitary gland—polycystic ovary syndrome	0.00644	0.0123	CbGeAlD
Acetazolamide—CA4—adipose tissue—polycystic ovary syndrome	0.00642	0.0123	CbGeAlD
Acetazolamide—CA1—endocrine gland—polycystic ovary syndrome	0.00639	0.0122	CbGeAlD
Acetazolamide—Drowsiness—Metformin—polycystic ovary syndrome	0.00638	0.0369	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00603	0.0349	CcSEcCtD
Acetazolamide—CA4—adrenal gland—polycystic ovary syndrome	0.00576	0.011	CbGeAlD
Acetazolamide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0057	0.033	CcSEcCtD
Acetazolamide—CA4—female gonad—polycystic ovary syndrome	0.00537	0.0103	CbGeAlD
Acetazolamide—CA2—pituitary gland—polycystic ovary syndrome	0.00534	0.0102	CbGeAlD
Acetazolamide—CA2—adipose tissue—polycystic ovary syndrome	0.00532	0.0102	CbGeAlD
Acetazolamide—Flushing—Metformin—polycystic ovary syndrome	0.00531	0.0308	CcSEcCtD
Acetazolamide—CA4—endocrine gland—polycystic ovary syndrome	0.00499	0.00954	CbGeAlD
Acetazolamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00488	0.0283	CcSEcCtD
Acetazolamide—CA2—adrenal gland—polycystic ovary syndrome	0.00477	0.00912	CbGeAlD
Acetazolamide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00462	0.0268	CcSEcCtD
Acetazolamide—Malaise—Metformin—polycystic ovary syndrome	0.00449	0.026	CcSEcCtD
Acetazolamide—CA2—female gonad—polycystic ovary syndrome	0.00445	0.00851	CbGeAlD
Acetazolamide—CA2—vagina—polycystic ovary syndrome	0.00442	0.00846	CbGeAlD
Acetazolamide—Discomfort—Metformin—polycystic ovary syndrome	0.00419	0.0243	CcSEcCtD
Acetazolamide—CA2—endocrine gland—polycystic ovary syndrome	0.00414	0.00791	CbGeAlD
Acetazolamide—Shock—Metformin—polycystic ovary syndrome	0.004	0.0232	CcSEcCtD
Acetazolamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00398	0.0231	CcSEcCtD
Acetazolamide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00365	0.0211	CcSEcCtD
Acetazolamide—Somnolence—Metformin—polycystic ovary syndrome	0.00362	0.0209	CcSEcCtD
Acetazolamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00358	0.0207	CcSEcCtD
Acetazolamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00354	0.0205	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00351	0.0203	CcSEcCtD
Acetazolamide—Fatigue—Metformin—polycystic ovary syndrome	0.00351	0.0203	CcSEcCtD
Acetazolamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00335	0.0194	CcSEcCtD
Acetazolamide—Urticaria—Metformin—polycystic ovary syndrome	0.00323	0.0187	CcSEcCtD
Acetazolamide—Asthenia—Metformin—polycystic ovary syndrome	0.00292	0.0169	CcSEcCtD
Acetazolamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00278	0.0161	CcSEcCtD
Acetazolamide—Dizziness—Metformin—polycystic ovary syndrome	0.00269	0.0156	CcSEcCtD
Acetazolamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00267	0.0051	CbGeAlD
Acetazolamide—Vomiting—Metformin—polycystic ovary syndrome	0.00259	0.015	CcSEcCtD
Acetazolamide—Headache—Metformin—polycystic ovary syndrome	0.00255	0.0148	CcSEcCtD
Acetazolamide—Nausea—Metformin—polycystic ovary syndrome	0.00242	0.014	CcSEcCtD
Acetazolamide—CA14—Metabolism—CYP11A1—polycystic ovary syndrome	0.000413	0.00136	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—RRM2—polycystic ovary syndrome	0.00041	0.00135	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—RRM2—polycystic ovary syndrome	0.00041	0.00135	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—MTHFR—polycystic ovary syndrome	0.000408	0.00134	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NAMPT—polycystic ovary syndrome	0.000407	0.00134	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NAMPT—polycystic ovary syndrome	0.000407	0.00134	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000402	0.00132	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000402	0.00132	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—NCOR1—polycystic ovary syndrome	0.000401	0.00132	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMMR—polycystic ovary syndrome	0.000396	0.0013	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—YAP1—polycystic ovary syndrome	0.000396	0.0013	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—YAP1—polycystic ovary syndrome	0.000396	0.0013	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000394	0.0013	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000393	0.00129	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SULT2A1—polycystic ovary syndrome	0.000393	0.00129	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKR1C3—polycystic ovary syndrome	0.00039	0.00128	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000386	0.00127	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP17A1—polycystic ovary syndrome	0.000384	0.00126	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—RRM2—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NAMPT—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NAMPT—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKR1C3—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKR1C3—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP1A1—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMMR—polycystic ovary syndrome	0.00038	0.00125	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000378	0.00124	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000377	0.00124	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000376	0.00124	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP11A1—polycystic ovary syndrome	0.000375	0.00123	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000375	0.00123	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—STAR—polycystic ovary syndrome	0.000374	0.00123	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000374	0.00123	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000374	0.00123	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000372	0.00122	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—YAP1—polycystic ovary syndrome	0.000366	0.0012	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000362	0.00119	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000362	0.00119	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—LHB—polycystic ovary syndrome	0.000359	0.00118	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000354	0.00117	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKR1C3—polycystic ovary syndrome	0.000354	0.00117	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—MTHFR—polycystic ovary syndrome	0.000354	0.00116	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.000352	0.00116	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000351	0.00115	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000349	0.00115	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000349	0.00115	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000348	0.00114	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—LHB—polycystic ovary syndrome	0.000345	0.00113	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00034	0.00112	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000337	0.00111	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMMR—polycystic ovary syndrome	0.000334	0.0011	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TH—polycystic ovary syndrome	0.000332	0.00109	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PPARG—polycystic ovary syndrome	0.000331	0.00109	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—LHB—polycystic ovary syndrome	0.00033	0.00109	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000328	0.00108	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—POMC—polycystic ovary syndrome	0.000326	0.00107	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000326	0.00107	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—INS—polycystic ovary syndrome	0.000325	0.00107	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TH—polycystic ovary syndrome	0.000323	0.00106	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000323	0.00106	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000323	0.00106	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000323	0.00106	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000323	0.00106	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000318	0.00105	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000315	0.00103	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000315	0.00103	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000313	0.00103	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000313	0.00103	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000306	0.001	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000304	0.000999	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000304	0.000998	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000303	0.000997	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000302	0.000993	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000302	0.000993	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.0003	0.000987	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0003	0.000986	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000296	0.000973	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000296	0.000973	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000294	0.000966	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000294	0.000966	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000292	0.000961	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000291	0.000956	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.00029	0.000955	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000288	0.000946	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPARG—polycystic ovary syndrome	0.000287	0.000944	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000284	0.000933	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—POMC—polycystic ovary syndrome	0.000283	0.000931	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—INS—polycystic ovary syndrome	0.000282	0.000926	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000281	0.000923	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.00028	0.000921	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TH—polycystic ovary syndrome	0.00028	0.00092	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—RRM2—polycystic ovary syndrome	0.000279	0.000916	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000277	0.000912	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000276	0.000908	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000276	0.000908	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000275	0.000904	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000272	0.000895	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000271	0.000891	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.000269	0.000885	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—YAP1—polycystic ovary syndrome	0.000269	0.000883	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000267	0.000877	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000266	0.000874	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000264	0.000868	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000264	0.000868	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GNAS—polycystic ovary syndrome	0.000264	0.000868	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000262	0.000861	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000258	0.000849	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NAMPT—polycystic ovary syndrome	0.000258	0.000849	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000258	0.000849	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000258	0.000848	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000256	0.000841	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000255	0.000838	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000253	0.000832	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000252	0.000827	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NCOR1—polycystic ovary syndrome	0.000252	0.000827	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000251	0.000825	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000249	0.000819	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000247	0.000813	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000246	0.00081	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000246	0.00081	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000246	0.00081	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000246	0.000808	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000246	0.000807	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000245	0.000806	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000245	0.000804	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000241	0.000791	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000238	0.000784	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000238	0.000784	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000237	0.000779	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000236	0.000776	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000235	0.000772	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000235	0.000772	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000228	0.000751	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.000228	0.00075	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000227	0.000746	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000226	0.000745	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000225	0.000738	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000224	0.000737	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TH—polycystic ovary syndrome	0.000223	0.000733	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000732	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000732	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000222	0.000731	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—polycystic ovary syndrome	0.000222	0.000731	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000221	0.000725	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000218	0.000715	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000218	0.000715	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000217	0.000713	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TH—polycystic ovary syndrome	0.000214	0.000703	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.000696	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000208	0.000685	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000208	0.000684	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000682	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000682	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.000206	0.000678	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000205	0.000675	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000205	0.000674	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TH—polycystic ovary syndrome	0.000205	0.000674	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000204	0.000671	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000202	0.000665	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000199	0.000656	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000196	0.000643	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000192	0.000632	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000188	0.00062	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000188	0.000617	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000185	0.000608	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000184	0.000604	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000182	0.0006	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000182	0.000599	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—INS—polycystic ovary syndrome	0.000181	0.000596	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.00018	0.000593	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.00018	0.000593	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.00018	0.000593	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000179	0.000588	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000178	0.000584	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000178	0.000584	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.000177	0.000581	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—INS—polycystic ovary syndrome	0.000177	0.000581	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000175	0.000577	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000175	0.000574	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000173	0.00057	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000168	0.000553	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000168	0.000553	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	0.000167	0.00055	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000166	0.000547	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000166	0.000546	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000166	0.000546	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000165	0.000543	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000165	0.000543	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000165	0.000542	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000164	0.000541	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000162	0.000534	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00016	0.000526	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	0.000159	0.000524	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000158	0.000518	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000156	0.000513	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000154	0.000506	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000153	0.000504	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000153	0.000503	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000151	0.000497	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000147	0.000484	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000147	0.000483	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000141	0.000463	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.00014	0.000461	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000133	0.000437	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000131	0.00043	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000129	0.000424	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000124	0.000409	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000124	0.000407	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000123	0.000403	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.000122	0.000401	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000119	0.000392	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000118	0.000386	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000117	0.000384	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000115	0.000378	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	0.000114	0.000376	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—POMC—polycystic ovary syndrome	0.000113	0.000371	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—INS—polycystic ovary syndrome	0.000112	0.000368	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000105	0.000346	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000105	0.000346	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.0001	0.00033	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—POMC—polycystic ovary syndrome	9.91e-05	0.000326	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—INS—polycystic ovary syndrome	9.85e-05	0.000324	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.78e-05	0.000322	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	9.75e-05	0.000321	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.32e-05	0.000274	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.32e-05	0.000274	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.97e-05	0.000229	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.61e-05	0.000217	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.3e-05	0.000207	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.62e-05	0.000185	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.36e-05	0.000176	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.89e-05	0.000161	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.78e-05	0.000157	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.63e-05	0.000152	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.26e-05	0.00014	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.12e-05	0.000136	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.98e-05	0.000131	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.82e-05	0.000126	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.77e-05	0.000124	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.56e-05	0.000117	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.51e-05	0.000115	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.03e-05	9.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.95e-05	9.71e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.78e-05	9.12e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.48e-05	8.14e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.36e-05	7.76e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.24e-05	7.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.09e-05	6.86e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.69e-05	5.56e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.67e-05	5.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.66e-05	5.45e-05	CbGpPWpGaD
